Hedge Fund and Insider Trading News: Dan Loeb, Bridgewater Associates, Catalio Capital Management, Apple Inc (AAPL), NervGen Pharma Corp (NGENF), and More

Bridgewater Associates, Former Co-CEO Eileen Murray Settle Compensation Dispute (Reuters)
(Reuters) – Bridgewater Associates said on Monday that former co-Chief Executive Officer Eileen Murray has settled a compensation dispute with the world’s biggest hedge fund nearly two and a half months after filing suit against the company. The terms of the settlement, which was reported earlier by the Wall Street Journal, were not disclosed.

Billionaire Investor Dan Loeb Follows Warren Buffett and Marc Benioff into Snowflake (Business Insider)
Billionaire investor Dan Loeb has followed Warren Buffett and Marc Benioff into Snowflake, the cloud-data platform that went public last month and saw its stock price more than double during its first day of trading. Loeb’s Third Point fund counted Snowflake among its winning investments in September, its latest portfolio update shows. However, it didn’t disclose the size of its stake or when it was purchased.

Catalio Capital Management LP Closes Oversubscribed Venture Fund II at $100 Million Hard Cap (Businesswire.com)
NEW YORK–(BUSINESS WIRE) — Catalio Capital Management LP (Catalio), a prominent life sciences investment firm, announced today the close of its second venture fund, Catalio Nexus II. The fund was oversubscribed and closed at its hard cap of $100 million, backed by private equity and hedge fund investors, as well as institutional family offices and foundations. In addition to closing its largest fund to date, Catalio announced the opening of a flagship office in Manhattan to facilitate the firm’s rapid growth. Catalio has raised nearly $150 million since inception and invested in 20 innovative, high-growth life sciences companies founded or referred by an elite group of world-renowned serial scientist-entrepreneurs who serve as Venture Partners.

Insider Trading Eyeglasses

Alex Oakenman / shutterstock.com

Three Top Tips for Investing in Innovative Asia-Pacific Companies (Preqin.com)
Three private equity specialists share how they identify companies with breakout potential and back their growth. Asia-Pacific-focused private equity & venture capital assets under management surged to a record-high $1.29tn in 2019, a 34% increase from 2018. Strategies targeting more innovative and faster-growth sectors hold the bulk of dry powder, but how do you pick a winner? At Preqin’s Private Equity & Venture Capital Driving Innovation in Asia-Pacific webinar on 29 September, we heard from Permira Principal Shane Lauf, Vickers Venture Partners Founder Dr Finian Tan, and VI Ventures Founding Partner Dr Tianhong Xu.

EQT Closes Second Real Estate Fund at $1.18bn, Exceeds the Target (Opalesque.com)
Stockholm-based private equity firm has reached the final close of its second real estate fund with a €1bn ($1.18bn) hard cap, 33% above its initial €750m target. The vehicle, EQT Real Estate II, was launched in 2018 and is over twice the size of its predecessor, wrapped up in 2017 at €420m. “The successful fundraise of EQT Real Estate II exceeded its target size of EUR 750 million and, at EUR 1 billion, is more than 2.5 times larger than its predecessor fund, EQT Real Estate I,” said a company statement. Real Estate II will execute “a thematic investment approach with a focus on attractive investments which are decoupled from the financial cycle,” it added.

A Quant Who Won Big in the 2008 Crisis Is Back With a 45% Gain (Bloomberg)
The pandemic roller coaster is reviving the fortunes of a long-suffering quant trader who last won big in 2008. After shedding assets amid lackluster returns through much of the decade’s stock bull run, Roy Niederhoffer’s Diversified Fund has gained 45% this year through September — set for its best year since a 57% return notched in the global financial crisis.

Hedge Fund Industry Welcomes Removal of Cayman from EU Tax ‘Blacklist’ (Hedge Week)
The hedge fund industry has welcomed a decision by the European Union to remove the Cayman Islands – a major offshore domicile for the global hedge fund industry – from a tax haven blacklist. The Alternative Investment Management Association, the hedge fund industry’s global trade body, said the move was “good news” for the international alternative asset management community. In February, the Economic and Financial Affairs Council (ECOFIN) – which comprises the 27 EU member states’ finance and economics ministers – agreed to add Cayman to an EU list of ‘non-cooperative’ tax jurisdictions.

Third Point Takes Stake in Buffett-Backed Snowflake (Reuters)
(Reuters) – Billionaire investor and hedge fund owner Daniel Loeb told clients that one of his portfolios nursed small losses last month but was helped by positions in Snowflake Inc (SNOW) and Pinterest Inc (PINS), two fast-growing technology companies. The Third Point Offshore Fund is now up 3.6% for the year after slipping 0.7% in September following a gain of 8.4% in August.

Apple Inc (AAPL) COO Jeffrey E Williams Sold $29.2 million of Shares (Guru Focus)
COO of Apple Inc., Jeffrey E Williams, sold 257,343 shares of AAPL on 10/02/2020 at an average price of $113.59 a share. The total sale was $29.2 million. Apple Inc is designs, manufactures and markets mobile communication and media devices and personal computers, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications.

The Chairman of NervGen Pharma (Other OTC: NGENF) is Selling Shares (Analyst Ratings)
Today, the Chairman of NervGen Pharma (NGENF), William Joseph Radvak, sold shares of NGENF for $585K. Currently, NervGen Pharma has an average volume of 49.23K. The Company has a Price to Book ratio of 10.69. The insider sentiment on NervGen Pharma has been positive according to 10 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Pfizer Named Top Dividend Stock With Insider Buying And 4.18% Yield (Forbes)
In this series, we look through the most recent Dividend Channel ”DividendRank” report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider’s view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money – maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So when stocks turn up that see insider buying, and are also top dividends, investors are wise to take notice. One such company is Pfizer, which saw buying by Director Ronald E. Blaylock.

Catalent Inc (CTLT) Chair & CEO John R Chiminski Sold $15.7 million of Shares (Guru Focus)
Chair & CEO of Catalent Inc., John R Chiminski, sold 182,231 shares of CTLT on 10/02/2020 at an average price of $86.01 a share. The total sale was $15.7 million. Catalent Inc is a drug development, delivery and supply partner company. It engages in advanced delivery technologies and development solutions for drugs, biologics, and consumer health products across US, Europe and other international markets.